1. Home
  2. RMCF vs NEPH Comparison

RMCF vs NEPH Comparison

Compare RMCF & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocky Mountain Chocolate Factory Inc.

RMCF

Rocky Mountain Chocolate Factory Inc.

HOLD

Current Price

$2.34

Market Cap

27.2M

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$2.92

Market Cap

31.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMCF
NEPH
Founded
1981
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.2M
31.0M
IPO Year
2024
2004

Fundamental Metrics

Financial Performance
Metric
RMCF
NEPH
Price
$2.34
$2.92
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
17.5K
29.9K
Earning Date
01-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1000.00
EPS
N/A
0.11
Revenue
$30,432,352.00
$18,789,000.00
Revenue This Year
N/A
$11.24
Revenue Next Year
N/A
$11.58
P/E Ratio
N/A
$26.18
Revenue Growth
N/A
32.67
52 Week Low
$1.14
$1.78
52 Week High
$2.99
$6.42

Technical Indicators

Market Signals
Indicator
RMCF
NEPH
Relative Strength Index (RSI) 51.97 41.71
Support Level $1.47 $2.79
Resistance Level $2.59 $3.21
Average True Range (ATR) 0.13 0.16
MACD 0.01 0.04
Stochastic Oscillator 87.93 70.52

Price Performance

Historical Comparison
RMCF
NEPH

About RMCF Rocky Mountain Chocolate Factory Inc.

Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, U-Swirl Operations, and Other t. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: